Arm

The market cap is ~$447B on $0.85 GAAP EPS — a ~495× trailing P/E. Analyst consensus price target is ~$269 against a ~$419 spot price, implying -36% downside to consensus. Even the most optimistic forward P/E estimates of ~71–89× are double the semiconductor sector median of ~37×. What earnings scenario justifies $447B?

All figures are from the sheet's sourced data: market cap ~$447B, GAAP EPS $0.85 FY2026, trailing P/E ~495×, forward P/E range ~71–193× (wide spread due to EPS definition), from stockanalysis.com (2026-06-17, secondary). Semiconductor sector median ~37× per Damodaran/NYU Stern. Analyst consensus ~$269 vs. ~$419 spot = -36% implied downside. The sourced bull case: data-center royalty >2× YoY in Q4 FY2026, ~50% hyperscaler CPU share, CSS licenses scaling (16 / 10 companies shipping), royalty revenue $2,613M (+21%) FY2026. The sheet concedes the growth is real but notes multiples price years of Armv9/CSS/Neoverse mix-shift already partially delivered into a tiny GAAP earnings base.

Related-party revenue from SoftBank common-control entities jumped to $1,499M — roughly 30.5% of total FY2026 revenue — up 82% YoY, with license revenue from related parties up $591M or 141%. How do you verify arm's-length economics when the buyer is also your 86% controlling shareholder?

The figures are primary: related-party revenue $1,499M FY2026 (~30.5%) vs. $823M FY2025 (~20.5%) per the Q4 FYE26 condensed income statement. The 20-F MD&A confirms the $676M (+82%) increase was "primarily driven by a $591M (+141%) increase in license" revenue from common-control/SoftBank-related entities. Contract assets from related parties tripled: $646M (Mar 2026) vs. $152M prior year. The sheet labels this "not circular leverage" but notes arm's-length economics are "harder to verify" and that controlled-company governance limits minority oversight of related-party terms. SoftBank holds 922,733,999 shares (86.4%); Arm is a Nasdaq controlled company.

Remaining performance obligations fell 7% YoY to $2,071M and the Q1 FY2027 guidance midpoint is $1.26B — a sequential step-down from Q4 FY2026 actual of $1.49B. If the royalty growth story is intact, why is forward visibility thinning right now?

Both figures are primary from the Q4 FYE26 shareholder letter: RPO $2,071M (-7% YoY vs. $2,226M); Q1 FY2027 revenue guide $1.26B ± $50M vs. Q4 FY2026 actual $1.49B. Management attributes the RPO decline to improvements in timing of revenue conversion and notes that future royalties are excluded from RPO by policy — so the royalty stream itself is not in the RPO figure. ACV was $1,660M (+22%), showing the licensing pipeline still growing. The sheet's position: RPO declining and a soft Q1 guide signal "forward visibility thinning even as trailing growth looks strong" — the fragility is valuation + hyperscaler-capex dependency, not an operational collapse story.